ArticleOncology and therapy2026

Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases.

Surbhi Sidana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.